Introduction
============

Directed enzyme evolution is a protein‐engineering method that harnesses natural selection at the molecular level and directs the evolution of proteins that are customized to meet desired specifications ([@b34]; [@b18]). In general, it involves several sequential steps --*in vitro* generation of a DNA mutant library, transformation of the DNA mutant library in the host and selection/screening of protein mutants. *Escherichia coli* is the most used workhorse for directed enzyme evolution because of its high transformation efficiency (\> 10^9^ per µg of DNA) and simple operation, but it is difficult to screen enzymes whose substrates (e.g. cellulose and starch) cannot be transported across the cell membrane. In these cases, cell lysis must be conducted before enzyme activity is screened.

*Bacillus subtilis* is a good host for the production of secretory proteins ([@b25]; [@b29]; [@b20]; [@b32]). Screening or selection of secretory enzymes (e.g. amylase, subtilisin and cellulase) based on *B. subtilis* would save a great deal of time spent on enzyme assays and characterization ([@b21]; [@b1]; [@b34]). Different from *E. coli*, direct transformation of *B. subtilis* with a DNA mutant library prepared based on restriction enzymes and ligation is inefficient ([@b4]). DNA mutant libraries for secretory enzymes (e.g. subtilisin, amylase) are usually constructed in *E. coli* and then the DNA plasmid mutant library purified from *E. coli* is transferred into competent *B. subtilis* cells ([@b7]; [@b15]; [@b9]; [@b5]). As shown in [Fig. 1A](#f1){ref-type="fig"}, the routine protocol based on the *B. subtilis*--*E. coli* shuttle vectors is time‐consuming, labour‐intensive and of low efficiency ([@b30]; [@b37]; [@b5]). Furthermore, the passage of a random DNA library through *E. coli* may introduce bias by selectively removing or amplifying certain clones ([@b23]; [@b21]).

![Flow schemes of the routine method and the new method for library construction in *B. subtilis*.](mbt0004-0098-f1){#f1}

The *B. subtilis* competent cells are usually prepared using a two‐step procedure involving two types of minimal media ([@b8]). For relatively high transformation efficiencies (∼10^3^--10^4^ transformants per µg of DNA), the cell growth curve must be monitored carefully ([@b10]; [@b8]). The reported highest transformation efficiencies of *B. subtilis* are ∼1--3 × 10^6^ transformants per µg of DNA, either by using the two‐step procedure with multimeric plasmids ([@b21]) or by using a high‐osmolarity electroporation method ([@b28]). But both methods are labour‐intensive, time‐consuming and hard to be operated by beginners.

To decrease the labour required for cloning and obtain high *B. subtilis* transformation efficiencies sufficient for directed evolution of secretory enzymes, we prepared supercompetent *B. subtilis* cells that can be efficiently transformed by foreign DNA and multimeric plasmids. We modified *B. subtilis* 1A751 ([@b27]) by overexpressing its competence master regulator ComK ([@b24]), where the *comk* gene is controlled by the xylose‐inducible promoter *P~xylA~* ([@b11]). The supercompetent cells were made by adding 1% (w/v) xylose into the cells growing in the exponential phase for 2 h. Because *B. subtilis* prefers to be transformed by multimeric plasmids rather than monomeric ones ([@b4]), Shafikhani *et al*. have produced multimeric plasmids by using overlap PCR based on two templates: a DNA mutant library made by error‐prone PCR and a linearized plasmid prepared by digestion with a restriction enzyme ([@b21]; [@b6]). Here we modified the Shafikhani protocol by generating a linear plasmid backbone by using high‐fidelity PCR so that this operation can be conducted anywhere in the plasmid ([Fig. 2B](#f2){ref-type="fig"}). As shown in [Fig. 1A](#f1){ref-type="fig"}, it takes about 1 week for the routine method to construct mutant libraries in *B. subtilis* through the shuttle vector if every step goes smoothly. In contrast, the new protocol is simple (restriction enzyme‐, phosphatase‐, and ligase‐free), fast (i.e. 1 day) and of high efficiency (i.e. 10^7^ per µg of DNA) ([Fig. 1B](#f1){ref-type="fig"}). In this study, the secretory expression level and specific activity of glycoside hydrolase family 5 endoglucanse were improved through this new system.

![PCR‐based gene mutagenesis and plasmid multimerization. A. Relevant features of the vector pNWP43N‐Bscel5. *P~43~*, *SP~nprB~*, *Bscel5* and *term* represent the *P~43~* promoter, the NprB signal peptide‐encoding sequence, gene of family 5 endoglucanse and terminator of *Bscel5* from *B. subtilis* respectively. *ColE1 ori*, *repB* and *cat* represent the sequences coding for the ColE1 replication origin, replicase and chloramphenicol resistance marker respectively. The arrows show the transcription directions for these genes. B. The flow scheme of the two‐step PCR procedure for the gene mutagenesis and plasmid multimerization. *gh5*, family 5 glycoside hydrolase‐encoding sequence; *cbm3*, family 3 carbohydrate‐binding module‐encoding sequence. P1, P2, P3 and P4 denote the positions of the primers for the PCR amplification. This figure was not drawn to scale. C. Plasmid multimerization by PCR. Lanes: M, DNA markers; 1, PCR‐linearized pNWP43N‐Bscel5; 2, error‐prone PCR product of *SPnprB‐Bscel5*; 3, multimerized plasmid; 4, multimer digested with PstI/HindIII.](mbt0004-0098-f2){#f2}

Results
=======

Mutagenesis of Bscel5 and plasmid multimerization using two‐step PCR
--------------------------------------------------------------------

For the recombinant expression and secretion of *B. subtilis* family 5 endoglucanase BsCel5, the *B. subtilis--E. coli* shuttle vector pNWP43N‐Bscel5 was constructed. It contained a 1480 bp NprB signal peptide‐encoding sequence and a mature BsCel5‐encoding gene, under the control of a strong *P~43~* promoter ([@b31]) ([Fig. 2A](#f2){ref-type="fig"}). First, the 1480 bp fragment in vector pNWP43N‐Bscel5 was mutagenized by error‐prone PCR with the primer pair P3/P4 ([Fig. 2B](#f2){ref-type="fig"}). Second, the vector pNWP43N‐Bscel5 was linearized with high‐fidelity PCR by using primers P1 and P2 ([Fig. 2B](#f2){ref-type="fig"}). The locations of P1/P2 can be randomly chosen between the locations of primers P3/P4, which is independent of the restriction enzyme cutting site. Third, multimeric plasmids were generated using high‐fidelity overlap PCR based on the two templates -- a linearized vector and a mutagenized *SP~nprB~‐Bscel5* library at a molar ratio of ∼1:100. Such a low ratio of the vector to the mutant fragment decreases the possibility of multimeric plasmid formation based on the vector itself so to decreases the possibility of background false positives. The product after overlap PCR was multimeric plasmids with a yield of ∼100 ng of DNA per µl. High‐molecular‐weight multimeric plasmids did not migrate in agarose gel using regular electrophoresis ([Fig. 2C](#f2){ref-type="fig"}, lane 3). After the PstI and HindIII digestion, the digested product of the multimeric plasmid showed two fragments, 3572 bp and 1416 bp ([Fig. 2C](#f2){ref-type="fig"}, lane 4), in good agreement with the PstI‐ and HindIII‐digested monomeric plasmid pNWP43N‐Bscel5.

Transformation of *B. subtilis* SCK6
------------------------------------

ComK of *B. subtilis* is the master regulator for competence development. The induction of *comK* combined with positive autostimulation of native *comK* results in an increased percentage of competent cells in the population ([@b13]; [@b22]; [@b14]). In this study, an extra copy of the *comK* gene was integrated at the *B. subtilis* 1A751 *lacA* locus ([Fig. 3](#f3){ref-type="fig"}) of the chromosome and placed under the control of the xylose‐inducible promoter *P~xylA~* ([@b11]), resulting in a new recombinant *B. subtilis* SCK6 that can be easily converted to a supercompetent cell by induction with 1% xylose in the Luria--Bertani (LB) medium.

![Construction of *B. subtilis* SCK6. The sequence between two homologous arms (*lacA*′ and ′*lacA*) was replaced by the xylose‐inducible *comK* expression cassette from the linearized pAX01‐comK via a double‐crossing‐over recombination. X indicates one cross‐over event. *lacA*′ and ′*lacA*, upstream and downstream sequences of the *B. subtilis lacA* gene respectively; *erm*, erythromycin resistance gene; *comK*, *B. subtilis comK* gene; *p~xylA~*, xylose‐inducible promoter of *xylA* gene; *xylR*, *B. subtilis xyl* operon repressor; *t~lacA~*, terminator of *B. subtilis lacA* gene; *t~1~t~2~* and *t~0~*, terminators of lambda phage.](mbt0004-0098-f3){#f3}

The induced supercompetent cells of *B. subtilis* strain SCK6 exhibited transformation efficiencies of ∼1 × 10^7^ transformants per µg of multimeric plasmid DNA. The supercompetent cells also had good transformation efficiencies of ∼1 × 10^4^ per µg of ligated plasmid DNA prepared from the regular cloning process.

Cellulase mutant screening based on insoluble cellulose substrate
-----------------------------------------------------------------

The transformed cells containing vector pNWP43N‐Bscel5 were spread on LBR plates containing 0.4% regenerated amorphous cellulose (RAC) and then were incubated at 37°C for 20 h. Because secretory BsCel5 can hydrolyse insoluble cellulose on solid agar plates, it resulted in transparent halos ([Fig. 4A and B](#f4){ref-type="fig"}). The bigger and clearer halo zones indicate that the corresponding cells can secrete a more active enzyme and/or secrete a larger quantity of cellulase. Under the tested mutation conditions, about 48.8% of the clones were estimated to harbour the inactivated enzyme mutants. In [Fig. 4A](#f4){ref-type="fig"}, a positive mutant with a bigger and clearer halo zone compared with wild‐type or negative clones was identified from the plate. Three mutants (MT1, MT2 and MT3) with bigger and clearer halo zones were screened from ∼16 000 colonies on about 20 Petri plates.

![Cellulase mutant library screening for Bscel5 variants. A. A positive mutant with bigger and clearer halo zone (red arrow) was screened. B. Comparison of the performance of wild type (WT) and mutants (MT1, MT2 and MT3) based on the ability to degrade insoluble cellulose, which forms clear halo zones. The *B. subtilis* strains were streaked on an LBR plate and incubated for 24 h at 37°C. C. BsCel5 expression and secretion profiles of wild type and mutants. M, protein markers; −, negative control. For whole cells fraction, the protein samples corresponding to 10 µl cell culture were loaded for each lane. For medium fraction, the proteins precipitated from 100 µl of culture supernatant were loaded for each lane. The position of BsCel5 is indicated with arrows. D. Base mutations in *Bscel5* variants. Red bars indicate the base mutations in the variants.](mbt0004-0098-f4){#f4}

The three selected mutants and another four randomly selected clones were sequenced to estimate the mutation rates. The mutation sites in the three selected mutants were summarized in [Table 1](#t1){ref-type="table"}. The overall mutation rate for error‐prone PCR was ∼0.3%. There were two to seven mutations for the selected positive clones. The three positive mutants had one to two mutations in the signal peptide‐encoding region and several mutations in the catalytic module and carbohydrate‐binding module ([Fig. 4D](#f4){ref-type="fig"}). The other randomly selected neutral or negative mutants did not contain any mutation in their signal peptide‐encoding sequence (data not shown).

###### 

Amino acid substitutions in the selected BsCel5 mutants and the corresponding base mutations.

  Mutant   Amino acid substitution and corresponding base mutation
  -------- -------------------------------------------------------------------------------------
  MT1      T16I (ACA→ATA), S27P (TCA→CCA), K33I (AAA→ATA), I339T (ATT→ACT), A465\* (GCA→GCT)
  MT2      S8\* (TCT→TCA), A30\* (GCA→GCT), T97S (ACG→TCG), S189\* (TCA→TCT), Y280\* (TAT→TAC)
  MT3      T7\* (ACA→ACG), K474E (AAA→GAA), K482E (AAA→GAA)

The asterisk (\*) stands for the silent mutation.

[Figure 4B](#f4){ref-type="fig"} shows the growth of strains harbouring one of the three mutants or wild‐type BsCel5 on an LBR plate. After washing the cells from the plate, it was clearly visible that these mutant enzymes had a significant increased ability to hydrolyse RAC compared with the wild‐type enzyme ([Fig. 4B](#f4){ref-type="fig"}). To check the expression level of secretory BsCel5, the strains harbouring wild‐type *Bscel5* and mutants were cultivated in a modified 2×L‐Mal medium for 72 h and protein profiles of whole cells fraction and medium fraction were checked with SDS‐PAGE ([Fig. 4C](#f4){ref-type="fig"}). Compared with the wild‐type strain ([Fig. 4C](#f4){ref-type="fig"}, WT), the much stronger bands of BsCel5 observed for all the mutants (∼52 kDa, [Fig. 4C](#f4){ref-type="fig"}) in the whole cells fraction indicated that the expression levels of BsCel5 mutants were elevated after the directed evolution. For the medium fraction, all the BsCel5 mutants became the major extracellular protein ([Fig. 4C](#f4){ref-type="fig"}), suggesting enhanced secretory protein expression levels as compared with the wild type. Because the signal peptide‐encoding sequences often have significant effects on secretion efficiencies of proteins ([@b26]), the elevated secretory expression levels for the three positive mutants were highly likely attributed to the mutations located in signal peptide‐encoding sequences.

The wild‐type BsCel5 and mutants were overexpressed in *E. coli* and then were purified to homogeneity (data not shown). As shown in [Fig. 5](#f5){ref-type="fig"}, the specific activities of mutant MT1 and MT2 were comparable to that of wild type, while mutant MT3 exhibited a ∼45% increase in the specific activity on RAC.

![Relative specific activities of wild‐type BsCel5 (WT) and its mutants (MT1, MT2 and MT3). The specific activity of wild‐type BsCel5 under the tested condition is ∼698 U µmol^−1^. The error bars represent the standard deviation of the triplicate measurements.](mbt0004-0098-f5){#f5}

Discussion
==========

A combination of supercompetent cells and multimeric plasmids resulted in a simple, fast and high‐efficiency transformation system for directed evolution of secretory enzymes in *B. subtilis*. A new *Bacillus* host SCK6 from *B. subtilis* 1A751 ([@b27]) was constructed, in which an extra copy of the *comK* gene was placed under the control of xylose‐inducible promoter on the chromosome. After a short period of xylose induction in the LB medium, this engineered strain is ready to be transformed at high efficiencies of more than 10^7^ per µg of multimeric plasmid and ∼10^4^ per µg of ligated plasmid. Because of the two order‐of‐magnitude cell density difference between supercompetent *B. subtilis* cells (∼2 × 10^8^) and competent *E. coli* cells (∼2--3 × 10^10^ cfu ml^−1^) ([@b19]), much higher transformation efficiency based on the same amount of DNA is expected when the supercompetent *B. subtilis* cells are concentrated by centrifugation. In practice, an extra step for cell concentration is not necessary because the efficiency of 10^7^ per µg of multimeric plasmid is high enough for directed evolution. The utilization of this supercompetent cell also enabled us to simplify cloning in *B. subtilis* without relying on *E. coli--B. subtilis* shuttle vectors any more.

In addition, it was important to construct the library for directed enzyme evolution directly in *B. subtilis* to avoid the risk of bias. We found that some plasmids with *Bscel5* mutant obtained from *B. subtilis* library cannot transform *E. coli* for unknown reasons (data not shown).

It was long known that *B. subtilis* prefers to be transformed by multimeric plasmids rather than monomers ([@b4]). In this study, we described a modified procedure for generating multimeric plasmids based on the previous work of Shafikhani *et al*. ([@b21], [@b6]). The linear vector was made by PCR process so that this operation is completely independent of the use of restriction enzymes and ligase. Any region on the expression vector can be subjected to random mutagenesis, for example, the promoter, a part of a gene, the replication origin and so on.

In summary, we have developed a simple, fast and high‐efficiency method for directed evolution of secretory enzymes based on *B. subtilis*. The advantages of this new platform are: (i) large library (∼10^7^ transformants per µg of DNA), (ii) no risk of bias, (iii) mutagenesis can target any region of the vector, (iv) very easy and robust transformation protocol and (v) restriction enzyme‐, phosphatase‐ and ligase‐free. A glycoside hydrolase family 5 endoglucanse mutant exhibited both enhanced secretory expression level and specific activity on RAC was obtained through this system. This new system would be very useful for efficient transformation of *B. subtilis*, directed evolution of secretory enzymes and knockout or insertion of genes using high‐throughput methods.

Note: The integration vector pAX01‐comK for xylose‐inducible ComK overexpression and supercompetent *B. subtilis* strain SCK6 can be obtained from the *Bacillus* Genetic Stock Center (<http://www.bgsc.org>) with the Accession No. ECE222 and 1A976 respectively.

Experimental procedures
=======================

Chemicals and materials
-----------------------

All chemicals were reagent grade or higher, purchased from Sigma (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA) unless otherwise noted. All enzymes for molecular biology experiments were purchased from New England Biolabs (Ipswich, MA). RAC was prepared from Avicel as previously described ([@b35]).

Bacterial strains, plasmids and oligonucleotides
------------------------------------------------

The bacterial strains and plasmids used in this study are listed in [Table 2](#t2){ref-type="table"}. The primers ([Table 3](#t3){ref-type="table"}) used for the PCR amplification were synthesized by Integrated DNA Technologies. All microorganisms were grown in the LB medium, LBR medium \[LB medium containing 0.4% (w/v) RAC\] or the modified 2×L‐Mal medium ([@b2]). The final concentrations of antibiotics were 100 µg ml^−1^ ampicillin and 25 µg ml^−1^ chloramphenicol for *E. coli* and 5 µg ml^−1^ chloramphenicol and 1 µg ml^−1^ erythromycin for *B. subtilis*.

###### 

Strains and plasmids.

  Strain or plasmid   Characteristics                                                                                                                           Reference
  ------------------- ----------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------
  *E. coli*                                                                                                                                                     
   JM109              *recA*1, *supE*44 *endA*1 *hsdR*17 (^r−^k, ^m+^k) *gyrA*96 *relA*1 *thi* (*lac*‐*proAB*) F\'\[*traD*36 *proAB*^+^*lacI*^q^*lacZ Δ*M15\]   [@b19])
   BL21 Star (DE3)    F^‐^*ompT hsdS*B (rB^‐^mB^‐^) *gal dcm rne131* (DE3)                                                                                      Invitrogen, Carlsbad, CA
  *B. subtilis*                                                                                                                                                 
   168                *trpC*2                                                                                                                                   [@b3])
   1A751              *his nprR*2 *nprE*18 Δ*aprA*3 Δ*eglS*102 Δ*bglT bglS*RV                                                                                   [@b27])
   SCK6               Erm^R^, 1A751 derivate, *lacA*::P*~xylA~*‐*comK*                                                                                          This work
  Plasmids                                                                                                                                                      
   pP43NMK            Amp^R^, Km^R^, *E. coli--B. subtilis* shuttle vector                                                                                      [@b31])
   pP43N‐Bscel5       Amp^R^, Km^R^, pP43NMK derivate with Bs*cel5* gene cloned                                                                                 This work
   pNW33N             Cm^R^, *E. coli--B. subtilis* shuttle vector                                                                                              *Bacillus* Genetic Stock Center
   pNWP43N‐Bscel5     Cm^R^, pNW33N derivate, with Bs*cel5* expression cassette cloned                                                                          This work
   pAX01              Amp^R^, Erm^R^, *B. subtilis* integrative vector, xylose‐inducible promoter                                                               [@b11])
   pAX01‐comK         Amp^R^, Erm^R^, pAX01 derivate with *comK* cloned                                                                                         This work
   pET20b             Amp^R^, overexpression vector containing T7‐dependent promoter                                                                            Novagen, Madison, WI

Amp^R^, ampicillin resistance; Cm^R^, chloramphenicol resistance; Erm^R^, erythromycin resistance; Km^R^, kanamycin resistance.

###### 

Oligonucleotides used in this study.

  Primer   Sequence
  -------- --------------------------------------------
  P1       5′‐CAAAGGAGCACCTATTTTTGTGAC‐3′
  P2       5′‐CTGAGTGCATAGTTTGCTTTATCC‐3′
  P3       5′‐GGTAAGAGAGGAATGTACACATG‐3′
  P4       5′‐GCTTAACTAATTTGGTTCTGTTC‐3′
  P5       5′‐CTAGCTGCAGCAGGGACAAAAACGCC‐3′
  P6       5′‐GATACCCGGGCACAACGCAAACCTCC‐3′
  P7       5′‐GCATACGGATCCAAAGGAGGCCATAATATGAGTCAG‐3′
  P8       5′‐CCTGATCCGCGGCTATTTTTCTAATACCGTTCC‐3′
  P9       5′‐GTGATAGCGGTACCATTATAG‐3′
  P10      5′‐ACGCAAACCTCCTATTAGATG‐3′

Construction of plasmids
------------------------

The DNA sequence encoding mature BsCel5 (30--499 amino acids) (GenBank Accession No.: CAA82317) and its following terminator sequence were amplified from genomic DNA of *B. subtilis* 168 with the primer pair P5/P6. The PCR product was digested with PstI/XmaI and ligated into the corresponding sites of the vector pP43NMK ([@b31]) to generate pP43N‐Bscel5, where the *Bscel5* gene without its signal peptide‐encoding fragment was fused with *B. subtilis* protease NprB signal peptide‐encoding sequence. After the digestion of pP43N‐Bscel5 with BamHI/XmaI, the smaller fragment containing the *P~43~‐SP~nprB~‐Bscel5‐term* expression cassette was cloned into the corresponding sites of a *B. subtilis--E. coli* shuttle vector pNW33N to generate pNWP43N‐Bscel5 ([Fig. 2A](#f2){ref-type="fig"}).

Preparation of a supercompetent *B. subtilis* host -- SCK6
----------------------------------------------------------

The ComK‐encoding sequence was amplified from the genomic DNA of *B. subtilis* 168 with the primer pair P7/P8. The SD sequence (AAAGGAGG) of *B. subtilis gsiB* gene ([@b16]) was introduced upstream of the amplified *comK* gene. The PCR product was digested with BamHI/SacII and ligated into the corresponding sites of the vector pAX01 ([@b11]) to generate pAX01‐comK, where the *comK* gene was placed under the control of xylose‐inducible *P~xylA~* promoter. *Bacillus subtilis* 1A751 ([@b27]) was transformed with the PciI‐linearized pAX01‐comK. After the double‐cross‐over recombination between linearized pAX01‐comK and chromosomal DNA at the *lacA* locus ([Fig. 3](#f3){ref-type="fig"}), the recombinants were selected on an LB plate with 1 µg ml^−1^ erythromycin. Disruption of the *lacA* gene and insertion of the *comK* gene were verified by PCR and the identified recombinant strain was designated as *B. subtilis* SCK6.

PCR‐based random mutagenesis
----------------------------

A randomly mutated library of SP*~nprB~*‐BsCel5‐encoding sequence ([Fig. 2B](#f2){ref-type="fig"}) was generated by error‐prone PCR (0.5 ng µl^−1^ plasmid pNWP43N‐Bscel5 as the template, 0.2 mM dATP, 0.2 mM dGTP, 1 mM dCTP, 1 mM dTTP, 5 mM MgCl~2~, 0.2 mM MnCl~2~, 0.05 U µl^−1^ polymerase, and 0.4 µM each of the primers P3 and P4). The PCR reaction was conducted by using the NEB *Taq* DNA polymerase (94°C denaturation, 2 min; 13 cycles of 94°C denaturation, 30 s; 50°C annealing, 30 s; and 68°C extension, 1.5 min, followed by 68°C extension for 5 min).

pNWP43N‐Bscel5 linearization by PCR
-----------------------------------

The plasmid pNWP43N‐Bscel5 (4988 bp) was linearized by high‐fidelity PCR by using the primer pair P1/P2. The PCR reaction was conducted using NEB Phusion DNA polymerase (98°C denaturation, 1 min; 30 cycles of 98°C denaturation, 10 s; 56°C annealing, 20 s; and 72°C extension, 75 s, followed by 72°C extension for 5 min).

Plasmid multimerization by overlap PCR
--------------------------------------

The linearized pNWP43N‐Bscel5 and error‐prone PCR product were cleaned with a Zymo Research DNA Clean & Concentrator Kit. The multimerization process was conducted with a modified protocol of [@b21]), using high‐fidelity PCR (dNTP, 0.2 mM for each; error‐prone PCR product, 5 ng µl^−1^; PCR‐linearized pNWP43N‐Bscel5, 0.15 ng µl^−1^; polymerase, 0.04 U µl^−1^). The PCR reaction was conducted using Phusion DNA polymerase (98°C denaturation, 30 s; 20 cycles of 98°C denaturation, 10 s; 72°C annealing and extension, 3 min, 15 cycles of 98°C denaturation, 10 s; 72°C annealing and extension, 6 min, followed by 72°C extension for 10 min). For the quantification of the multimerization products, the PCR product was digested with HindIII, and then was subjected to agarose gel electrophoresis and analysed with Quantity One (Version 4.6.7).

Preparation and transformation of supercompetent *B. subtilis* cells
--------------------------------------------------------------------

The *B. subtilis* SCK6 strain was inoculated into 3 ml of LB medium with 1 µg ml^−1^ erythromycin in a test tube. The cells were cultivated at 37°C with shaking at 200 r.p.m. overnight (∼12 h). The culture was then diluted to *A*~600~ at 1.0 in a fresh LB medium containing 1% (w/v) xylose and then grown for 2 h. The resulting cell culture was ready to be transformed or divided into aliquots and stocked at −80°C with 10% (v/v) glycerol.

One microlitre of the PCR product containing plasmid multimers was mixed with 100 µl of the supercompetent cells in a plastic test tube and cultivated at 37°C with shaking at 200 r.p.m. for 90 min. An aliquot of the transformed cells was diluted by 10^3^‐ to 10^4^‐fold for estimating the transformation efficiency. To facilitate the further segregation of different clones in the same cell ([@b21]), the rest of the transformed cells were diluted into 10 ml of M9 minimal medium containing 5 µg ml^−1^ chloramphenicol and grown at 37°C for 14 h. The cell cultures were then diluted by 20‐fold with the same medium and grown for an additional 8 h. The serial diluted transformants were spread on LBR plates containing 5 µg ml^−1^ chloramphenicol and incubated at 37°C for 20 h. Positive colonies that were surrounded with big and clear halo zones were selected for further characterization and DNA sequencing using the primer pair P9/P10.

Cellulase production and analysis in *B. subtilis*
--------------------------------------------------

The *B. subtilis* strains were cultivated in a modified 2×L‐Mal medium ([@b2]) at 30°C for 72 h. After centrifugation, the extracellular proteins in the supernatant were precipitated using the DOC‐TCA method ([@b17]). Protein samples were analysed by using 12% (w/v) SDS‐PAGE.

Endoglucanase expression, purification and assays
-------------------------------------------------

For intracellular expression of wild‐type BsCel5 and mutants in *E. coli*, the wild‐type *Bscel5* and its mutants were subcloned into pET20b (Novagen, Madison, WI) without their signal peptide‐encoding sequence. *Escherichia coli* BL21 Star (DE3) (Invitrogen, Carlsbad, CA) were transformed with the recombinant plasmids for expressing the target proteins. The recombinant BsCel5 was purified based on its ability to strongly bind RAC, followed by desorption by ethylene glycol ([@b12]; [@b33]). The BsCel5 activity was measured in a 50 mM MES buffer (pH 6.0) containing 1 mM CaCl~2~ and 1% RAC (w/v) at 50°C for 30 min. The reactions were terminated by boiling at 100°C for 5 min and the concentrations of newly released soluble reducing sugars were determined by the 2,2′‐bicinchoninate (BCA) method ([@b36]). One unit of activity was defined as the amount of enzyme that released 1 µmol of reducing end per minute.
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